Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Chemoradiation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04886635
What this trial is testing

Surgery As Needed for Oesophageal Cancer - 2

Who this might be right for
Cancer of Esophagus
Bas P. L. Wijnhoven 360
Large-scale testing (Phase 3)UnknownNCT03038217
What this trial is testing

Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Peking Union Medical College Hospital 300
Early research (Phase 1)Study completedNCT03792347
What this trial is testing

Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hecheng Li M.D., Ph.D 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07596290
What this trial is testing

Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC

Who this might be right for
Locally Advanced Rectal AdenocarcinomaNeoadjuvant ChemoradiationNeoadjuvant Immunotherapy
Beijing Friendship Hospital 342
Not applicableLooking for participantsNCT03465982
What this trial is testing

Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer

Who this might be right for
Rectal Cancer
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria 340
Not applicableUnknownNCT03493880
What this trial is testing

The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments

Who this might be right for
Gastric CancerNeoadjuvant ChemotherapyNeoadjuvant Chemoradiotherapy+2 more
Peking University 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT02008656
What this trial is testing

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Who this might be right for
Rectal Cancer
Memorial Sloan Kettering Cancer Center 358
Large-scale testing (Phase 3)Study completedNCT00274937
What this trial is testing

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer

Who this might be right for
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7+5 more
Children's Oncology Group 111
Not applicableUnknownNCT02527057
What this trial is testing

Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
Hunan Province Tumor Hospital 90
Large-scale testing (Phase 3)UnknownNCT03623737
What this trial is testing

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaChemoradiation
National Taiwan University Hospital 248
Testing effectiveness (Phase 2)Looking for participantsNCT07153445
What this trial is testing

Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung CancerStage IIIA Lung CancerStage IIIB Lung Cancer
Fundación GECP 97
Testing effectiveness (Phase 2)Study completedNCT03165994
What this trial is testing

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Esophageal CancerGastroEsophageal Cancer
Apexigen America, Inc. 34
Testing effectiveness (Phase 2)Study completedNCT04009876
What this trial is testing

Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Fundación de investigación HM 30
Large-scale testing (Phase 3)UnknownNCT04557020
What this trial is testing

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Who this might be right for
Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital 200
Not applicableUnknownNCT05070832
What this trial is testing

Hyperthermia Combined With Neoadjuvant Radiochemotherapy for LARC

Who this might be right for
HyperthermiaRadiotherapy
Peking University Third Hospital 142
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Testing effectiveness (Phase 2)Looking for participantsNCT06601309
What this trial is testing

Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital 90
Large-scale testing (Phase 3)Study completedNCT01404156
What this trial is testing

Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma

Who this might be right for
Esophageal CancerAdenocarcinoma, EsophagealAdenocarcinoma, Gastroesophageal Junction
Dr. Gordon Buduhan 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07829783
What this trial is testing

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer (MK-2870-055)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 400
Testing effectiveness (Phase 2)WithdrawnNCT04989283
What this trial is testing

Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI)
Next Page